Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.

Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

Five months ago, Roseline Phay, a 32-year-old farmer from the West African nation of Liberia, set off on a quest to find ...

Petitioner says some sections were changed without public participation. High Court told the new law was hurt overburden ...

Players in the health sector have commended the approval of the first-ever malaria drug for babies weighing less than five ...

The declaration of Suriname as the first malaria-free Amazonian country by the World Health Organization should spur other ...

Brazilian researchers have discovered chemical compounds in marine sponges that have the potential to eliminate the malaria ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight ...

Welcome to the Daily News Brief, CFR’s flagship morning newsletter summarizing the top global news and analysis of the ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...